{{Rsnum
|rsid=10486003
|Chromosome=7
|position=97600466
|Orientation=plus
|GMAF=0.1157
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 79.6 | 20.4 | 0.0
| HCB | 60.6 | 32.8 | 6.6
| JPT | 69.0 | 28.3 | 2.7
| YRI | 100.0 | 0.0 | 0.0
| ASW | 92.9 | 7.1 | 0.0
| CHB | 60.6 | 32.8 | 6.6
| CHD | 53.7 | 39.8 | 6.5
| GIH | 79.2 | 19.8 | 1.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 81.8 | 18.2 | 0.0
| MKK | 99.3 | 0.7 | 0.0
| TSI | 76.5 | 23.5 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22020760
|Trait=None
|Title=Polymorphic markers associated with severe oxaliplatin-induced, chronic peripheral neuropathy in colon cancer patients.
|RiskAllele=
|Pval=5E-7
|OR=3.1300
|ORtxt=None
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}